Your browser doesn't support javascript.
loading
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
Klempner, Samuel J; Bendell, Johanna C; Villaflor, Victoria Meucci; Tenner, Laura LaNiel; Stein, Stacey M; Rottman, James B; Naik, Girish S; Sirard, Cynthia A; Kagey, Michael H; Chaney, Marya F; Strickler, John H.
Afiliação
  • Klempner SJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. sklempner@partners.org.
  • Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee.
  • Villaflor VM; Northwestern University, Chicago, Illinois.
  • Tenner LL; University of Texas Health Science Center, San Antonio, Texas.
  • Stein SM; Yale School of Medicine, New Haven, Connecticut.
  • Rottman JB; Athenaeum Pathology Consulting, LLC, Sudbury, Massachusetts.
  • Naik GS; Leap Therapeutics, Cambridge, Massachusetts.
  • Sirard CA; Leap Therapeutics, Cambridge, Massachusetts.
  • Kagey MH; Leap Therapeutics, Cambridge, Massachusetts.
  • Chaney MF; Merck & Co., Inc., Kenilworth, New Jersey.
  • Strickler JH; Duke University Medical Center, Durham, North Carolina.
Mol Cancer Ther ; 20(11): 2240-2249, 2021 11.
Article em En | MEDLINE | ID: mdl-34482288
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article